Related references
Note: Only part of the references are listed.Targeting SARS-CoV-2 M3CLpro by HCV NS3/4a Inhibitors: In Silico Modeling and In Vitro Screening
Anjela Manandhar et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2021)
SARS-CoV-2 M-pro inhibitors with antiviral activity in a transgenic mouse model
Jingxin Qiao et al.
SCIENCE (2021)
Cinnamon and Hop Extracts as Potential Immunomodulators for Severe COVID-19 Cases
Kurt Lucas et al.
FRONTIERS IN PLANT SCIENCE (2021)
Considerations for the discovery and development of 3-chymotrypsin-like cysteine protease inhibitors targeting SARS-CoV-2 infection
Koen Vandyck et al.
CURRENT OPINION IN VIROLOGY (2021)
Drug Design Strategies for the Treatment of Viral Disease. Plant Phenolic Compounds and Their Derivatives
Monika Kowalczyk et al.
FRONTIERS IN PHARMACOLOGY (2021)
Xanthohumol protects against Azoxymethane-induced colorectal cancer in Sprague-Dawley rats
Hualin Liu et al.
ENVIRONMENTAL TOXICOLOGY (2020)
Emerging coronaviruses: Genome structure, replication, and pathogenesis
Yu Chen et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
Emerging threats from zoonotic coronaviruses-from SARS and MERS to 2019-nCoV
Ping-Ing Lee et al.
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION (2020)
A Novel Coronavirus from Patients with Pneumonia in China, 2019
Na Zhu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection
Emmie de Wit et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
An Infectious cDNA Clone of SARS-CoV-2
Xuping Xie et al.
CELL HOST & MICROBE (2020)
Prostate and breast cancer cells death induced by xanthohumol investigated with Fourier transform infrared spectroscopy
Barbara Gieroba et al.
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Zhenming Jin et al.
NATURE (2020)
From SARS to SARS-CoV-2, insights on structure, pathogenicity and immunity aspects of pandemic human coronaviruses
Nikhil Kirtipal et al.
INFECTION GENETICS AND EVOLUTION (2020)
Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses
E. Susan Amirian et al.
ONE HEALTH (2020)
Vaccination against coronaviruses in domestic animals
Ian R. Tizard
VACCINE (2020)
Anti-HCV and anti-malaria agent, potential candidates to repurpose for coronavirus infection: Virtual screening, molecular docking, and molecular dynamics simulation study
Faezeh Sadat Hosseini et al.
LIFE SCIENCES (2020)
Swine acute diarrhea syndrome coronavirus replication in primary human cells reveals potential susceptibility to infection
Caitlin E. Edwards et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs
Zhe Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial
Ryan Bradley et al.
TRIALS (2020)
Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease
Lifeng Fu et al.
NATURE COMMUNICATIONS (2020)
Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication
Wayne Vuong et al.
NATURE COMMUNICATIONS (2020)
Drug binding dynamics of the dimeric SARS-CoV-2 main protease, determined by molecular dynamics simulation
Teruhisa S. Komatsu et al.
SCIENTIFIC REPORTS (2020)
Progress in Developing Inhibitors of SARS-CoV-2 3C-Like Protease
Qingxin Li et al.
MICROORGANISMS (2020)
Cholesterol 25-hydroxylase suppresses SARS-CoV-2 replication by blocking membrane fusion
Ruochen Zeng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Ebselen, Disulfiram, Carmofur, PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors
Chunlong Ma et al.
ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2020)
The Potential Role of Xanthohumol in SARS-CoV-2 Treatment-Globally Accessible and Economically Viable
Martyn Caplin et al.
NUTRITION AND DIETARY SUPPLEMENTS (2020)
Coronavirus Endoribonuclease Activity in Porcine Epidemic Diarrhea Virus Suppresses Type I and Type III Interferon Responses
Xufang Deng et al.
JOURNAL OF VIROLOGY (2019)
Therapeutic effect of Xanthohumol against highly pathogenic porcine reproductive and respiratory syndrome viruses
Xuewei Liu et al.
VETERINARY MICROBIOLOGY (2019)
Origin and evolution of pathogenic coronaviruses
Jie Cui et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Xanthohumol inhibits colorectal cancer cells via downregulation of Hexokinases II-mediated glycolysis
Wenbin Liu et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2019)
Xanthohumol inhibits PRRSV proliferation and alleviates oxidative stress induced by PRRSV via the Nrf2-HMOX1 axis
Xuewei Liu et al.
VETERINARY RESEARCH (2019)
Effect of xanthohumol on Th1/Th2 balance in a breast cancer mouse model
Wenchao Zhang et al.
ONCOLOGY REPORTS (2018)
Michael Acceptor-Based Peptidomimetic Inhibitor of Main Protease from Porcine Epidemic Diarrhea Virus
Fenghua Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Recent Progress in the Development of HIV-1 Protease Inhibitors for the Treatment of HIV/AIDS
Arun K. Ghosh et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Xanthohumol Induces Growth Inhibition and Apoptosis in Ca Ski Human Cervical Cancer Cells
Wai Kuan Yong et al.
EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE (2015)
Ligand-induced Dimerization of Middle East Respiratory Syndrome (MERS) Coronavirus nsp5 Protease (3CLpro) IMPLICATIONS FOR nsp5 REGULATION AND THE DEVELOPMENT OF ANTIVIRALS
Sakshi Tomar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2015)
Xanthohumol, a main prenylated chalcone from hops, reduces liver damage and modulates oxidative reaction and apoptosis in hepatitis C virus infected Tupaia belangeri
Mingbo Yang et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2013)
Xanthohumol Modulates Inflammation, Oxidative Stress, and Angiogenesis in Type 1 Diabetic Rat Skin Wound Healing
Raquel Costa et al.
JOURNAL OF NATURAL PRODUCTS (2013)
Peptide aldehyde inhibitors challenge the substrate specificity of the SARS-coronavirus main protease
Lili Zhu et al.
ANTIVIRAL RESEARCH (2011)
Xanthohumol enhances antiviral effect of interferon alpha-2b against bovine viral diarrhea virus, a surrogate of hepatitis C virus
Ni. Zhang et al.
PHYTOMEDICINE (2010)
Inhibition of bovine viral diarrhea virus in vitro by xanthohumol: Comparisons with ribavirin and interferon-α and implications for the development of anti-hepatitis C virus agents
Ni Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2009)
Production of authentic SARS-CoV Mpro with enhanced activity:: Application as a novel tag-cleavage endopeptidase for protein overproduction
Xiaoyu Xue et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Broad spectrum antiinfective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol metabolites
C Gerhauser
MOLECULAR NUTRITION & FOOD RESEARCH (2005)
Antiviral activity of hop constituents against a series of DNA and RNA viruses
VE Buckwold et al.
ANTIVIRAL RESEARCH (2004)
The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor
HT Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Coronavirus main proteinase (3CLpro) structure:: Basis for design of anti-SARS drugs
K Anand et al.
SCIENCE (2003)
Share Paper
